| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022687 |
| Receipt No. | R000025927 |
| Official scientific title of the study | Delayed type of allergic skin reaction to Candida Albicans in eosinophilic rhinosinusitis cases |
| Date of disclosure of the study information | 2016/06/10 |
| Last modified on | 2016/06/10 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Delayed type of allergic skin reaction to Candida Albicans in eosinophilic rhinosinusitis cases | |
| Title of the study (Brief title) | Delayed type of allergic skin reaction to Candida Albicans in eosinophilic rhinosinusitis cases | |
| Region |
|
|
| Condition | ||
| Condition | Eosinophirilic rinosiusitis. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Delayed type of allergic skin reaction to Candida Albicans in eosinophilic rhinosinusitis cases |
| Basic objectives2 | Others |
| Basic objectives -Others | pathophysiology of eosinophirilic rinosiusitis. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Recrudescence of postoperative eosinophirilic rinosiusitis at 3 month ago. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Allergic skin reaction | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Bilateral sinusitis | |||
| Key exclusion criteria | Cystic disease
Unilateral sinusitis Fungal rhinosinusitis Odontogenic sinusitis |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Shoji Matsune |
| Organization | Nippon Medical School Musashikosugi Hospital |
| Division name | Department of Otolaryngology |
| Address | 1-369,Kosugithyou,Nakahara-ku,Kanagawa,JAPAN |
| TEL | 044-733-5181 |
| sm1988@nms.ac.jp | |
| Public contact | |
| Name of contact person | Wakayama Nozomu |
| Organization | Nippon Medical School Musashikosugi Hospital |
| Division name | Department of Otolaryngology |
| Address | 1-369,Kosugithyou,Nakahara-ku,Kanagawa,JAPAN |
| TEL | 044-733-5181 |
| Homepage URL | |
| waka84@nms.ac.jp | |
| Sponsor | |
| Institute | Nippon Medical School |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Nippon Medical School Musashikosugi Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025927 |